[Genetic polymorphisms and liver diseases].
Bataller
R
R
Institut de Malalties Digestives. IDIBAPS. Hospital Clínic. Barcelona. España. bataller@med.unc.edu
D019943:Amino Acid Substitution; D001327:Autoimmune Diseases / Q000235:genetics; D018450:Disease Progression; D000431:Ethanol / Q000009:adverse effects / Q000493:pharmacokinetics; D005234:Fatty Liver / Q000235:genetics; D020022:Genetic Predisposition to Disease; D005838:Genotype; D006432:Hemochromatosis / Q000235:genetics; D000071020:Hemochromatosis Protein; D016174:Hepacivirus / Q000276:immunology; D019698:Hepatitis C, Chronic / Q000235:genetics / Q000276:immunology; D015395:Histocompatibility Antigens Class I / Q000235:genetics; D006801:Humans; D008107:Liver Diseases / Q000235:genetics*; D008108:Liver Diseases, Alcoholic / Q000235:genetics; D008565:Membrane Proteins / Q000235:genetics; D020125:Mutation, Missense; D011110:Polymorphism, Genetic
C103673:HFE protein, human; D000071020:Hemochromatosis Protein; D015395:Histocompatibility Antigens Class I; D008565:Membrane Proteins; D000431:Ethanol